(0387–0429) Pediatric Rheumatology – Clinical Poster I

Sunday, October 26, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

Implementing Social Drivers of Health Screening for Patients with Pediatric Systemic Lupus Erythematosus
Abstract Poster Presenter: Julia Harris, MD – Children's Mercy Kansas City
10:30 AM - 12:30 PM Central Time

Macrophage activation syndrome-associated proteins and enhanced interferon gamma responsiveness characterize the plasma proteome of patients with Multisystem Inflammatory Syndrome in Children (MIS-C) in a pre-treatment replication single center cohort
Abstract Poster Presenter: Sarah McCuaig, MD, PhD (she/her/hers) – Children's Hospital of Philadelphia
10:30 AM - 12:30 PM Central Time

Effects of Self-Reported Medication Barriers on Medication Adherence and Disease Activity in a Cohort of Patients with Juvenile Idiopathic Arthritis
Abstract Poster Presenter: Aditi Shaily, MD (she/her/hers) – UBMD
10:30 AM - 12:30 PM Central Time

Clinical Indicators of Methotrexate Response in Juvenile Idiopathic Arthritis (JIA) and JIA with Uveitis (JIA-U)
Abstract Poster Presenter: Abigale Jagger, DO (she/her/hers) – Cincinnati Children's
10:30 AM - 12:30 PM Central Time

Discordance Between Disease Activity and Patient-Reported Outcomes in Patients with Juvenile Idiopathic Arthritis
Abstract Poster Presenter: Julia Harris, MD – Children's Mercy Kansas City
10:30 AM - 12:30 PM Central Time

Improving Outcomes in Patients with Juvenile Idiopathic Arthritis through a Novel Chronic Condition Value-Based Care Program
Abstract Poster Presenter: Julia Harris, MD – Children's Mercy Kansas City
10:30 AM - 12:30 PM Central Time

Outcomes in Juvenile Idiopathic Arthritis Based on Geographic Region in the Pediatric Rheumatology Care and Outcomes Improvement Network Registry
Abstract Poster Presenter: Julia Harris, MD – Children's Mercy Kansas City
10:30 AM - 12:30 PM Central Time

Tofacitinib in Juvenile Idiopathic Arthritis: efficacy and safety in a clinical practice setting.
Abstract Poster Presenter: Vicenç Torrente-Segarra, PhD (he/him/his) – Hospital Comarcal Alt Penedés Garraf
10:30 AM - 12:30 PM Central Time

An International Delphi Survey for the Definition of New Classification Criteria for Juvenile Idiopathic Arthritis
Abstract Poster Presenter: Nicolino Ruperto, MD, MPH – Università Milano Bicocca and Fondazione IRCSS S. Gerardo dei Tintori
10:30 AM - 12:30 PM Central Time

Longitudinal Effectiveness of Abatacept in JIA: Results From an Ongoing JIA Registry
Abstract Poster Presenter: Daniel Lovell, MD, MPH – Cincinnati Children's Hospital Medical Center
10:30 AM - 12:30 PM Central Time

The Impact of Social Vulnerability Index Scores in Pediatric Uveitis
Abstract Poster Presenter: Minal Aundhia, MD – Cincinnati Children's Hospital Medical Center
10:30 AM - 12:30 PM Central Time

Quantifying Burden of Uveitis Care for Pediatric Uveitis Patients and Caregivers
Abstract Poster Presenter: Catherine Lavallee, MD – St. Christopher's Hospital for Children
10:30 AM - 12:30 PM Central Time

Efficacy of Tumor Necrosis Factor Inhibitors in Children Diagnosed With Non-Systemic Juvenile Idiopathic Arthritis ≤ 2 Years Old Using The Childhood Arthritis and Rheumatology Research Alliance Registry
Abstract Poster Presenter: Christina Gulla, DO – Hackensack University Medical Center
10:30 AM - 12:30 PM Central Time

Maternal Smoking During Pregnancy and Risk of Juvenile Idiopathic Arthritis (JIA): Triangulating Evidence from Polygenic Risk Scores and Meta-Analysis in Scandinavian Birth Cohorts
Abstract Poster Presenter: Vilde Øverlien Dåstøl, MD – Oslo University Hospital
10:30 AM - 12:30 PM Central Time

The Association of Obesity with Juvenile Spondyloarthritis
Abstract Poster Presenter: Katelyn Baggett, MD – Johns Hopkins University
10:30 AM - 12:30 PM Central Time

Comparing biomarkers associated with uveitis in tear fluid and serum samples of children with Juvenile Idiopathic Arthritis
Abstract Poster Presenter: Ilaria Maccora, MD, PhD (she/her/hers) – Rheumatology Unit, ERN ReCoNNET Center, Meyer Children's Hospital IRCCS, Florence, Italy
10:30 AM - 12:30 PM Central Time

The SOS project: to Switch Or to Swap After Adalimumab failure for the management of childhood non-infectious uveitis in an international cohort
Abstract Poster Presenter: Ilaria Maccora, MD, PhD (she/her/hers) – Rheumatology Unit, ERN ReCoNNET Center, Meyer Children's Hospital IRCCS, Florence, Italy
10:30 AM - 12:30 PM Central Time

Radiographic Assessment in Juvenile Spondyloarthritis: Evaluating the axJSpA Criteria Using Radiographs Alone Versus MRI
Abstract Poster Presenter: Pamela Weiss, MD – Childrens Hospital of Philadelphia
10:30 AM - 12:30 PM Central Time

Which score fits best? Correlation of clinical indices of Disease Activity and Ultrasound findings in Juvenile Idiopathic Arthritis during Transitional Care
Abstract Poster Presenter: Silvia Magni-Manzoni, MD – Bambino Gesù IRCCS Children's Hospital
10:30 AM - 12:30 PM Central Time

Risk Factors for Anti-Adalimumab Antibody Development in Pediatric Patients Using Adalimumab for Rheumatic Disease and Associated Conditions
Abstract Poster Presenter: Dawn Gist, MD (she/her/hers) – Baylor College of Medicine Pediatric Rheumatology
10:30 AM - 12:30 PM Central Time

Improving Access to Timely Joint Injections for Pediatric Rheumatology Patients – A Quality Improvement Initiative
Abstract Poster Presenter: Kendra Lauer, DO – UT Southwestern
10:30 AM - 12:30 PM Central Time

A Scoping Review of Outcomes of Adults with Childhood-onset Systemic Autoimmune Rheumatic Diseases
Abstract Poster Presenter: Kaien Gu, MD, FRCPC – Feinstein Institutes for Medical Research
10:30 AM - 12:30 PM Central Time

High Density Lipoprotein Dysfunction in Juvenile Idiopathic Arthritis as Compared to Children without Rheumatologic Disease
Abstract Poster Presenter: Tahnee Spoden, MD (she/her/hers) – UCLA
10:30 AM - 12:30 PM Central Time

Juvenile Idiopathic Arthritis Mimics: A Case Series on Progressive Pseudo-Rheumatoid Dysplasia and CACP Syndrome in Pediatric Patients from a Tertiary Center in South India
Abstract Poster Presenter: Sreelekha Kambhampati, MD – Nizams institute of medical sciences
10:30 AM - 12:30 PM Central Time

Juvenile Psoriatic Arthritis and Enthesitis-Related Arthritis: 4-Year Results From the JUNIPERA Extension Study
Abstract Poster Presenter: Hermine Brunner, MD, MSc, MBA – Cincinnati Children's Hospital Medical Center
10:30 AM - 12:30 PM Central Time

Evaluation of Disease Activity in the Knee Joint Through Clinical, Radiologic, Synovial Fluid and Histopathologic Measurements of Inflammation in Children with Juvenile Idiopathic Arthritis
Abstract Poster Presenter: Patricia Vega-Fernandez, MD, RhMSUS, MSc – Cincinnati Children's Hospital Medical Center
10:30 AM - 12:30 PM Central Time

Predicting JIA-Associated Uveitis Using Tear Fluid Biomarkers: A Prospective Multicenter Study
Abstract Poster Presenter: Mariia Pavlenko, MD – University of Colorado
10:30 AM - 12:30 PM Central Time

Paediatric uveitis - Retrospective comparison of cataract surgery outcomes with or without intraocular lens implantation from two tertiary centres in United Kingdom
Abstract Poster Presenter: Chaitra Govardhan, MBBS, MRCP – Bristol Royal Hospital for Children
10:30 AM - 12:30 PM Central Time

Inflammatory Orbital Diseases: Pediatric Case Series From a Tertiary Care Center
Abstract Poster Presenter: Rasha Elrefai, MD – Baylor College of Medicine
10:30 AM - 12:30 PM Central Time

Association Between Juvenile Arthritis and Physical Activity Levels in U.S. Children: A Cross-sectional Study Using the 2016–2021 National Survey of Children’s Health
Abstract Poster Presenter: Carolina Tamashiro, MD (she/her/hers) – UCSF
10:30 AM - 12:30 PM Central Time

Outcomes Of Children with Juvenile Idiopathic Arthritis Receiving Biological Disease-Modifying Anti-Rheumatic Drugs: Retrospective Analysis of A Real-World Experience From A Resource-Limited Setting
Abstract Poster Presenter: Narendra Bagri, MD (he/him/his) – All India Institute of Medical Sciences(AIIMS)
10:30 AM - 12:30 PM Central Time

Disease Extension in Children with Limited Juvenile Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
Abstract Poster Presenter: Eveline Wu, MD, MSc – UNC Chapel Hill
10:30 AM - 12:30 PM Central Time

Association Between Body Mass Index (BMI) and JIA Inactive Disease at One Year
Abstract Poster Presenter: Anna Sutton, MPH (she/her/hers) – University of Washington
10:30 AM - 12:30 PM Central Time

The OMERACT Juvenile Idiopathic Arthritis MRI Score for Active and Structural Lesions in the Sacroiliac Joints: Development and Validation in Two Longitudinal Cohorts
Abstract Poster Presenter: Walter P P. Maksymowych, MD, FRCPC, MRCP, FACP – University of Alberta
10:30 AM - 12:30 PM Central Time

Predictors of quality of Life in a longitudinal cohort of patients with Uveitis, Juvenile Idiopathic Arthritis, and JIA-associated uveitis
Abstract Poster Presenter: Andressa Guariento Alves, MD, PhD – The Childrens Hospital of Philadelphia
10:30 AM - 12:30 PM Central Time

Clinical Outcomes of Ultrasound Guidance for Corticosteroid Injections of the Ankle and Midfoot Joints and Tendon Sheaths in Children with Juvenile Idiopathic Arthritis
Abstract Poster Presenter: Rina Ferguson, MD, MBA (she/her/hers) – Seattle Children's Hospital
10:30 AM - 12:30 PM Central Time

Real-world experience of upadacitinib therapy in difficult-to-treat juvenile idiopathic arthritis: a case series of 24 patients
Abstract Poster Presenter: Xuemei Tang, MD, Professor, Chief Physician – Department of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders
10:30 AM - 12:30 PM Central Time

Ultrasound-Guided Synovial Biopsy in Children and Adolescents with Juvenile Arthritis: Initial Results
Abstract Poster Presenter: Patricia Vega-Fernandez, MD, RhMSUS, MSc – Cincinnati Children's Hospital Medical Center
10:30 AM - 12:30 PM Central Time

Implementation of a Communication Aid in Juvenile Idiopathic Arthritis Patient Visits, a Quality Improvement Study
Abstract Poster Presenter: Nazlican Civilibal Tang, MD (she/her/hers) – Washington University School of Medicine in St. Louis
10:30 AM - 12:30 PM Central Time

Long-term efficacy of intra-articular triamcinolone hexacetonide injections in juvenile idiopathic arthritis patients starting tumor necrosis factor inhibitor therapy: 48 weeks results from a randomized, open-label, blinded-assessor multicenter phase 4 trial - the MyJIA trial
Abstract Poster Presenter: Pernille Bøyesen, MD, PhD – Oslo University Hospital
10:30 AM - 12:30 PM Central Time

IL-6 as a Predictor of Response to Olokizumab in Polyarticular-Course Juvenile Idiopathic Arthritis: Results of the Phase 2 Clinical Trial
Abstract Poster Presenter: Ekaterina Alexeeva, MD, PhD – National Medical Research Center for Children’s Health Federal State Autonomous Institution of the Russian Federation Ministry of Health and I.M. Sechenov First Moscow State Medical University (Sechenovskiy University)
10:30 AM - 12:30 PM Central Time

External Validation of Claims-based Algorithms for Newly Diagnosed Juvenile Idiopathic Arthritis
Abstract Poster Presenter: Daniel Horton, MD, MS – Rutgers Robert Wood Johnson Medical School
10:30 AM - 12:30 PM Central Time

Recent Antibiotic Exposure and Response to Treatment of Juvenile Idiopathic Arthritis
Abstract Poster Presenter: Daniel Horton, MD, MS – Rutgers Robert Wood Johnson Medical School